← FDA Drug Approvals (Drugs@FDA)

APREPITANT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT · Approved 2020-10-21

Drug application

FDA Application #

ANDA211835

Application type

Abbreviated New Drug Application (Generic)

Brand name

APREPITANT

Generic name

APREPITANT

Active ingredients

APREPITANT

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

TORRENT

Manufacturer

Golden State Medical Supply, Inc.

First approval

2020-10-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown